<?xml version="1.0" encoding="UTF-8" ?>


<?xml-stylesheet href="http://www.giiresearch.com/rss/style.xsl" type="text/xsl" media="screen"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xml:lang="en">
<channel rdf:about="http://www.giiresearch.com/bio_report.shtml">
  <title>Market Research Reports for Biotechnology</title>
  <link>http://www.giiresearch.com/bio_report.shtml</link>
  <description>Market Research Reports for Biotechnology</description>
  <dc:publisher>Global Information, Inc.</dc:publisher>
  <dc:rights>(C) 2012 Global Information, Inc.</dc:rights>
  <dc:date>2012-02-15</dc:date>
  <sy:updatePeriod>daily</sy:updatePeriod>
  <items>
    <rdf:Seq>
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231459-future-nucleic-acid-testing-market-new-product.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231460-leading-nucleic-acid-testing-market-players.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231461-future-infectious-disease-nucleic-acid-testing.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231462-emerging-opportunities-cancer-nucleic-acid-testing.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231463-future-french-nucleic-acid-testing-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231464-future-german-nucleic-acid-testing-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231465-furure-italian-nucleic-acid-testing-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231466-future-japanese-nucleic-acid-testing-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231467-future-spanish-nucleic-acid-testing-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231468-future-uk-nucleic-acid-testing-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg231469-future-us-nucleic-acid-testing-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/ida231062-us-market-wound-tissue-management-2012.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs231114-analysis-microrna-tools-services-market-europe.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/id231424-cloud-security-biopharma-data-protection-secure.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/mama230633-biomarkers-market-discovery-technologies.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/wild229876-biomarker-partnering-terms-agreements.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi230025-immunomodulators-market-2017-immunosuppressant.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/hts230087-high-throughput-qpcr-assay-trends-2012.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/wild230289-companion-diagnostics-partnering-terms-agreements.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/wild230291-pharmacogenomics-partnering-terms-agreements.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/wild230295-personalized-medicine-partnering-terms-agreements.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc230632-antibody-drugs-technologies-global-markets.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/cei231275-companion-diagnostics-biomarker-development.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg177477-col-cancer-angi-antib.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg194065-triple-analysis-leukemia-angiogenesis-antibodies.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg195943-triple-analysis-lymphoma-angiogenesis-antibodies.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg207621-triple-analysis-lung-cancer-angiogenesis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg216992-triple-analysis-angiogenesis-antibodies-peptides.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg216993-triple-analysis-angiogenesis-cancer-vaccines.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg216994-triple-analysis-angiogenesis-protein-kinase.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg216995-triple-analysis-apoptosis-angiogenesis-antibodies.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg217012-triple-analysis-melanoma-angiogenesis-antibodies.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg217021-triple-analysis-pancreatic-cancer-angiogenesis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg217031-triple-analysis-prostate-cancer-angiogenesis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg227317-triple-analysis-apoptosis-angiogenesis-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg227318-triple-analysis-apoptosis-angiogenesis-protein.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/pai219518-2012-protein-electrophoresis-western-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dgpl229466-gauging-biosimilar-effect-will-market-boom-or-bust.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es229669-global-biosimilars-return-optimism.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs229697-us-tissue-engineering-markets.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/hts230086-label-free-binding-analysis-trends-2012.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/imarc231004-indian-antibody-market-report-forecast-evaluation.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi228473-endpoints-clinical-trials-cardiovascular-disorders.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd229182-immuno-chemistry-market-outlook-brics-brazil.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd229184-microbiology-culture-market-outlook-brics-brazil.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc228043-tissue-engineering-regeneration-technologies.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg166271-hematology-suppliers.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd228217-genetic-testing-market-outlook-brics-brazil-russia.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd228218-histology-cytology-market-outlook-brics-brazil.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd228220-haematology-brics-market-outlook-brics-brazil.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg228246-future-japanese-hematology-flow-cytometry-markets.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg228247-emerging-special-hematology-tests-flow-cytometry.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs228004-analysis-stem-cell-markets-unlocking-new-era.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/biof227599-strategic-development-neural-stem-progenitor-cell.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70915-diagnostics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70916-cell-therapy.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70918-proteomics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70919-neuroprotection.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70921-transdermal.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70922-animal-bio.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70924-medicine.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70928-drug-deli.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70930-rnai.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70931-gene-therapy.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70933-nanobio.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70934-central-nervous.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70936-cardiovascular.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70937-biomarkers.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70938-cytogenetics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70939-therapeutics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai84243-dna-sequ-tech.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai136243-biochips.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc224399-2011-biotechnology-research-review.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kl227816-stem-cells-worldwide-markets-transplantation-cord.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/ida227848-us-market-dental-bone-graft-substitutes-dental.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/cd228355-high-content-analysis-technologies-applications.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg194071-triple-analysis-leukemia-apoptosis-antibodies.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/ti228447-nucleic-acid-based-therapeutics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/mrg227374-european-markets-orthopedic-biomaterials-2012.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/mrg227375-asia-pacific-markets-orthopedic-biomaterials.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs227473-european-molecular-diagnostics-markets.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs227461-strategic-analysis-european-stem-cell-research.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs226614-analysis-european-biosimilars-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs226617-strategic-analysis-collagen-peptide-market-united.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs228274-frost-sullivan-2011-survey-sequencing-technologies.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg177473-col-cancer-apo-antibo.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg195939-triple-analysis-lymphoma-apoptosis-antibodies.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg207065-triple-analysis-breast-cancer-lung-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg207613-triple-analysis-lung-cancer-apoptosis-antibodies.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg216996-triple-analysis-apoptosis-antibodies-peptides.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg216997-triple-analysis-apoptosis-cancer-vaccines.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg216998-triple-analysis-apoptosis-protein-kinase.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg217001-triple-analysis-breast-cancer-apoptosis-antibodies.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg217015-triple-analysis-melanoma-apoptosis-antibodies.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg217023-triple-analysis-pancreatic-cancer-apoptosis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg217037-triple-analysis-prostate-cancer-apoptosis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg227316-analytical-tool-apoptosis-oncology.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fuji225702-stem-cells-regenerative-medicine-benchmarking.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs226599-european-pharmaceutical-biotech-contract.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kt229862-biobanking-medicine-technology-market-2012-2022.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs228271-specialty-physicians-discuss-their-opinions-united.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc229460-hot-topics-impact-biomarkers-alzheimers-disease-dx.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg166145-emerging-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg166199-laboratory-poc.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg223934-future-coagulation-testing-market-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi224312-monoclonal-antibodies-market-2017-multiple.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg225022-global-beta-2-microglobulin-testing-market-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg225023-global-ca-tumor-markers-growth-opportunities.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg225024-global-cea-testing-market-growth-opportunities.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg225025-global-occult-blood-testing-market-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg225026-global-prostatic-acid-phosphatase-testing-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg225027-global-pap-smear-hpv-testing-market-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg225028-global-psa-testing-market-growth-opportunities.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg225029-future-cell-surface-markers-us-europe-japan.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg225030-future-clinical-chemistry-immunodiagnostics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg225031-future-clinical-chemistry-market-us-europe-japan.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg225034-future-immunoprotein-diagnostics-market-us-europe.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg225035-world-clinical-chemistry-immunodiagnostics-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg225036-emerging-chemistry-immunodiagnostic-tests.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg225038-emerging-clinical-chemistry-immunodiagnostic.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg225039-emerging-coagulation-testing-technologies-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg225040-world-coagulation-market-key-players-strategic.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg225041-emerging-coagulation-tests-suppliers-developing.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg225051-world-molecular-diagnostics-market-facilities-test.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg225052-emerging-cancer-molecular-diagnostic-tests.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg225053-world-molecular-diagnostics-market-key-players.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg225054-emerging-molecular-diagnostic-applications.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg225055-world-molecular-diagnostics-market-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/rnc226592-global-mirna-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/mrg225459-us-markets-orthopedic-biomaterials-2012.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/mrg225463-us-markets-surgical-hemostats-internal-tissue.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/rb228156-innovations-molecular-diagnostics-infectious.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs224904-outlook-european-market-bioactive-collagen-peptide.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc224398-synthetic-biology-emerging-global-markets.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224788-future-french-clinical-chemistry-immunodiagnostics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224789-future-german-clinical-chemistry-immunodiagnostics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224790-future-italian-clinical-chemistry.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224791-future-japanese-clinical-chemistry.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224792-future-spanish-clinical-chemistry.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224793-future-uk-clinical-chemistry-immunodiagnostics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224794-future-us-clinical-chemistry-immunodiagnostics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224795-future-french-coagulation-market-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224796-future-german-coagulation-market-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224797-future-italian-coagulation-marke-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224798-future-japanese-coagulation-market-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224799-future-spanish-coagulation-market-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224800-future-uk-coagulation-market-growth-opportunities.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224801-future-us-coagulation-market-growth-opportunities.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224809-future-french-molecular-diagnostics-market-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224810-future-german-molecular-diagnostics-market-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224811-future-italian-molecular-diagnostics-market-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224812-future-japanese-molecular-diagnostics-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224813-future-spanish-molecular-diagnostics-market-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224814-future-uk-molecular-diagnostics-market-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg224815-future-us-molecular-diagnostics-market-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc229453-emerging-technologies-stem-cells.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs224898-strategic-analysis-us-next-generation-sequencing.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi224311-stem-cell-research-market-2017-strong-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/lmer224082-competitor-analysis-anti-infective-antibodies.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc229444-biotech-company-outlook-2016.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/arm223423-polymerase-chain-reaction-pcr-products-tools.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/arm223424-polymerase-chain-reaction-pcr-medical-application.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166026-antibodi-pepti-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166078-peptides-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg177486-col-cancer-antibo-pepti.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg194069-triple-analysis-leukemia-antibodies-peptides.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg195951-triple-analysis-lymphoma-antibodies-peptides.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg207639-triple-analysis-lung-cancer-antibodies-peptides.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg217000-triple-analysis-breast-cancer-antibodies-peptides.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg217007-triple-analysis-cancer-vaccines-antibodies.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg217013-triple-analysis-melanoma-antibodies-peptides.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg217022-triple-analysis-pancreatic-cancer-antibodies.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg217036-triple-analysis-prostate-cancer-antibodies.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg217040-triple-analysis-protein-kinase-inhibitors.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/ren223412-genetic-testing-market-forecast-global-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg224089-commercializing-peptides-cancer-faster-route.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/biof223139-stem-cell-research-products-opportunities-tools.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dgpl222810-biosimilar-drugs-europe-threat-or-opportunity.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/mrg223062-us-markets-soft-tissue-repair-devices-2012.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kt226943-next-generation-antibody-therapies-pipeline-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/arm222464-biorepositories-equipments-applications.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/arm222466-biorepositories-equipments-applications-global.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/arm222467-biorepositories-equipments-technologies-global.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/arm222468-biorepositories-applications-technologies-global.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/arm222469-biorepositories-applications-end-users-global.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/arm222471-biorepositories-technologies-end-users-global.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/arm222472-biorepositories-applications-ownership-global.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/arm222473-biorepositories-technologies-ownership-global.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/arm222474-biorepositories-equipments-ownership-global-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/arm222811-biorepositories-ownership-end-users-global-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/arm222812-biobanking-applications-global-market-watch-2009.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/arm222813-biobanking-technologies-global-market-watch-2009.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/arm222814-biobanking-equipments-global-market-watch-2009.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/arm222816-biobanking-ownership-global-market-watch-2009-2015.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/arm222817-biobanking-end-users-global-market-watch-2009-2015.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/infi222971-global-cardiac-markers-device-market-2010-2014.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/hts225420-3d-cell-culture-trends-2011.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc229431-canada-generics-biosimilars-overview.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi219214-gpcrs-drug-discovery-efforts-de-orphanize-novel.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/tk220781-cardiac-marker-diagnostic-testing-markets.html" />
    </rdf:Seq>
  </items>
</channel>
<item rdf:about="http://www.giiresearch.com/report/vpg231459-future-nucleic-acid-testing-market-new-product.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2012-02-14</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg231459-future-nucleic-acid-testing-market-new-product.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231460-leading-nucleic-acid-testing-market-players.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2012-02-14</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Leading Nucleic Acid testing Market Players</title>
  <link>http://www.giiresearch.com/report/vpg231460-leading-nucleic-acid-testing-market-players.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231461-future-infectious-disease-nucleic-acid-testing.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:date>2012-02-14</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future Infectious Disease Nucleic Acid Testing</title>
  <link>http://www.giiresearch.com/report/vpg231461-future-infectious-disease-nucleic-acid-testing.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231462-emerging-opportunities-cancer-nucleic-acid-testing.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-02-14</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Emerging Opportunities in Cancer Nucleic Acid Testing</title>
  <link>http://www.giiresearch.com/report/vpg231462-emerging-opportunities-cancer-nucleic-acid-testing.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231463-future-french-nucleic-acid-testing-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2012-02-14</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future French Nucleic Acid Testing Market Outlook</title>
  <link>http://www.giiresearch.com/report/vpg231463-future-french-nucleic-acid-testing-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231464-future-german-nucleic-acid-testing-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2012-02-14</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future German Nucleic Acid Testing Market Outlook</title>
  <link>http://www.giiresearch.com/report/vpg231464-future-german-nucleic-acid-testing-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231465-furure-italian-nucleic-acid-testing-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2012-02-14</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Furure Italian Nucleic Acid Testing Market Outlook</title>
  <link>http://www.giiresearch.com/report/vpg231465-furure-italian-nucleic-acid-testing-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231466-future-japanese-nucleic-acid-testing-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2012-02-14</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future Japanese Nucleic Acid Testing Market Outlook</title>
  <link>http://www.giiresearch.com/report/vpg231466-future-japanese-nucleic-acid-testing-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231467-future-spanish-nucleic-acid-testing-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2012-02-14</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future Spanish Nucleic Acid Testing Market Outlook</title>
  <link>http://www.giiresearch.com/report/vpg231467-future-spanish-nucleic-acid-testing-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231468-future-uk-nucleic-acid-testing-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2012-02-14</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future UK Nucleic Acid Testing Market Outlook</title>
  <link>http://www.giiresearch.com/report/vpg231468-future-uk-nucleic-acid-testing-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg231469-future-us-nucleic-acid-testing-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2012-02-14</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future US Nucleic Acid Testing Market Outlook</title>
  <link>http://www.giiresearch.com/report/vpg231469-future-us-nucleic-acid-testing-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/ida231062-us-market-wound-tissue-management-2012.html">
  <dc:language>en</dc:language>
  <dc:subject>Wound Care</dc:subject>
  <dc:date>2012-02-08</dc:date>
  <dc:creator>iData Research Inc.</dc:creator>
  <title>U.S. Market for Wound and Tissue Management 2012</title>
  <link>http://www.giiresearch.com/report/ida231062-us-market-wound-tissue-management-2012.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs231114-analysis-microrna-tools-services-market-europe.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:date>2012-02-07</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Analysis of MicroRNA Tools and Services Market in Europe</title>
  <link>http://www.giiresearch.com/report/fs231114-analysis-microrna-tools-services-market-europe.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/id231424-cloud-security-biopharma-data-protection-secure.html">
  <dc:language>en</dc:language>
  <dc:subject>IT Security</dc:subject>
  <dc:subject>Web-Service</dc:subject>
  <dc:date>2012-02-06</dc:date>
  <dc:creator>IDC</dc:creator>
  <title>Cloud Security and Biopharma: Data Protection and Secure User Access as Cloud Services Are Increasing Compliance and Lowering Costs</title>
  <link>http://www.giiresearch.com/report/id231424-cloud-security-biopharma-data-protection-secure.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/mama230633-biomarkers-market-discovery-technologies.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2012-02-02</dc:date>
  <dc:creator>Markets and Markets</dc:creator>
  <title>Biomarkers Market (Discovery Technologies, Applications &amp; Indications) - Global Trends, Opportunities &amp; Forecasts (2011 - 2020)</title>
  <link>http://www.giiresearch.com/report/mama230633-biomarkers-market-discovery-technologies.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/wild229876-biomarker-partnering-terms-agreements.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:date>2012-02-01</dc:date>
  <dc:creator>Current Partnering, a division of Wildwood Ventures Limited</dc:creator>
  <title>Biomarker Partnering Terms and Agreements</title>
  <link>http://www.giiresearch.com/report/wild229876-biomarker-partnering-terms-agreements.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi230025-immunomodulators-market-2017-immunosuppressant.html">
  <dc:language>en</dc:language>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2012-02-01</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Immunomodulators Market to 2017 - Immunosuppressant Antibodies to Replace Antimetabolites as the Highest Value Sector by 2017</title>
  <link>http://www.giiresearch.com/report/gbi230025-immunomodulators-market-2017-immunosuppressant.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/hts230087-high-throughput-qpcr-assay-trends-2012.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2012-02-01</dc:date>
  <dc:creator>HTStec Ltd</dc:creator>
  <title>High Throughput qPCR Assay Trends 2012</title>
  <link>http://www.giiresearch.com/report/hts230087-high-throughput-qpcr-assay-trends-2012.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/wild230289-companion-diagnostics-partnering-terms-agreements.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:subject>Personalized Medicine</dc:subject>
  <dc:date>2012-02-01</dc:date>
  <dc:creator>Current Partnering, a division of Wildwood Ventures Limited</dc:creator>
  <title>Companion Diagnostics Partnering Terms and Agreements</title>
  <link>http://www.giiresearch.com/report/wild230289-companion-diagnostics-partnering-terms-agreements.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/wild230291-pharmacogenomics-partnering-terms-agreements.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:date>2012-02-01</dc:date>
  <dc:creator>Current Partnering, a division of Wildwood Ventures Limited</dc:creator>
  <title>Pharmacogenomics Partnering Terms and Agreements</title>
  <link>http://www.giiresearch.com/report/wild230291-pharmacogenomics-partnering-terms-agreements.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/wild230295-personalized-medicine-partnering-terms-agreements.html">
  <dc:language>en</dc:language>
  <dc:subject>Personalized Medicine</dc:subject>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:date>2012-02-01</dc:date>
  <dc:creator>Current Partnering, a division of Wildwood Ventures Limited</dc:creator>
  <title>Personalized Medicine Partnering Terms and Agreements</title>
  <link>http://www.giiresearch.com/report/wild230295-personalized-medicine-partnering-terms-agreements.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc230632-antibody-drugs-technologies-global-markets.html">
  <dc:language>en</dc:language>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2012-02-01</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Antibody Drugs: Technologies and Global Markets</title>
  <link>http://www.giiresearch.com/report/bc230632-antibody-drugs-technologies-global-markets.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/cei231275-companion-diagnostics-biomarker-development.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2012-02-01</dc:date>
  <dc:creator>Cutting Edge Information</dc:creator>
  <title>Companion Diagnostics and Biomarker Development</title>
  <link>http://www.giiresearch.com/report/cei231275-companion-diagnostics-biomarker-development.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg177477-col-cancer-angi-antib.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2012-01-30</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Colorectal Cancer, Angiogenesis and Antibodies</title>
  <link>http://www.giiresearch.com/report/bg177477-col-cancer-angi-antib.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg194065-triple-analysis-leukemia-angiogenesis-antibodies.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2012-01-30</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Leukemia, Angiogenesis and Antibodies</title>
  <link>http://www.giiresearch.com/report/bg194065-triple-analysis-leukemia-angiogenesis-antibodies.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg195943-triple-analysis-lymphoma-angiogenesis-antibodies.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2012-01-30</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Lymphoma, Angiogenesis and Antibodies</title>
  <link>http://www.giiresearch.com/report/bg195943-triple-analysis-lymphoma-angiogenesis-antibodies.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg207621-triple-analysis-lung-cancer-angiogenesis.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2012-01-30</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Lung Cancer, Angiogenesis and Antibodies</title>
  <link>http://www.giiresearch.com/report/bg207621-triple-analysis-lung-cancer-angiogenesis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg216992-triple-analysis-angiogenesis-antibodies-peptides.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-01-30</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Angiogenesis, Antibodies and Peptides</title>
  <link>http://www.giiresearch.com/report/bg216992-triple-analysis-angiogenesis-antibodies-peptides.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg216993-triple-analysis-angiogenesis-cancer-vaccines.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Vaccines</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2012-01-30</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Angiogenesis, Cancer Vaccines and Antibodies</title>
  <link>http://www.giiresearch.com/report/bg216993-triple-analysis-angiogenesis-cancer-vaccines.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg216994-triple-analysis-angiogenesis-protein-kinase.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-01-30</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Angiogenesis, Protein Kinase Inhibitors and Antibodies</title>
  <link>http://www.giiresearch.com/report/bg216994-triple-analysis-angiogenesis-protein-kinase.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg216995-triple-analysis-apoptosis-angiogenesis-antibodies.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-01-30</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Apoptosis, Angiogenesis and Antibodies</title>
  <link>http://www.giiresearch.com/report/bg216995-triple-analysis-apoptosis-angiogenesis-antibodies.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg217012-triple-analysis-melanoma-angiogenesis-antibodies.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-01-30</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Melanoma, Angiogenesis and Antibodies</title>
  <link>http://www.giiresearch.com/report/bg217012-triple-analysis-melanoma-angiogenesis-antibodies.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg217021-triple-analysis-pancreatic-cancer-angiogenesis.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2012-01-30</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Pancreatic Cancer, Angiogenesis and Antibodies</title>
  <link>http://www.giiresearch.com/report/bg217021-triple-analysis-pancreatic-cancer-angiogenesis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg217031-triple-analysis-prostate-cancer-angiogenesis.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2012-01-30</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Prostate Cancer, Angiogenesis and Antibodies</title>
  <link>http://www.giiresearch.com/report/bg217031-triple-analysis-prostate-cancer-angiogenesis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg227317-triple-analysis-apoptosis-angiogenesis-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Vaccines</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2012-01-30</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Apoptosis, Angiogenesis and Cancer Vaccines</title>
  <link>http://www.giiresearch.com/report/bg227317-triple-analysis-apoptosis-angiogenesis-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg227318-triple-analysis-apoptosis-angiogenesis-protein.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-01-30</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Apoptosis, Angiogenesis and Protein Kinase Inhibitors</title>
  <link>http://www.giiresearch.com/report/bg227318-triple-analysis-apoptosis-angiogenesis-protein.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/pai219518-2012-protein-electrophoresis-western-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2012-01-25</dc:date>
  <dc:creator>Percepta Associates Inc.</dc:creator>
  <title>2012 Protein Electrophoresis &amp; Western Analysis Series 1 -  Life Science Dashboard</title>
  <link>http://www.giiresearch.com/report/pai219518-2012-protein-electrophoresis-western-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dgpl229466-gauging-biosimilar-effect-will-market-boom-or-bust.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-01-23</dc:date>
  <dc:creator>Doctor's Guide Publishing Limited (FirstWord Pharma)</dc:creator>
  <title>Gauging the Biosimilar Effect: will the market boom or bust?</title>
  <link>http://www.giiresearch.com/report/dgpl229466-gauging-biosimilar-effect-will-market-boom-or-bust.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/es229669-global-biosimilars-return-optimism.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2012-01-23</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>Global Biosimilars: A return to optimism?</title>
  <link>http://www.giiresearch.com/report/es229669-global-biosimilars-return-optimism.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs229697-us-tissue-engineering-markets.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:date>2012-01-23</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>U.S. Tissue Engineering Markets</title>
  <link>http://www.giiresearch.com/report/fs229697-us-tissue-engineering-markets.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/hts230086-label-free-binding-analysis-trends-2012.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2012-01-23</dc:date>
  <dc:creator>HTStec Ltd</dc:creator>
  <title>Label-Free Binding Analysis Trends 2012</title>
  <link>http://www.giiresearch.com/report/hts230086-label-free-binding-analysis-trends-2012.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/imarc231004-indian-antibody-market-report-forecast-evaluation.html">
  <dc:language>en</dc:language>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2012-01-20</dc:date>
  <dc:creator>IMARC Group</dc:creator>
  <title>Indian Antibody Market Report &amp; Forecast: An Evaluation of Diagnostic &amp; Therapeutic Antibodies</title>
  <link>http://www.giiresearch.com/report/imarc231004-indian-antibody-market-report-forecast-evaluation.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi228473-endpoints-clinical-trials-cardiovascular-disorders.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2012-01-16</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Endpoints - Clinical Trials in Cardiovascular Disorders - Optimal Use of Surrogate Endpoints and Clinical Biomarkers are Key Determinants of Success</title>
  <link>http://www.giiresearch.com/report/gbi228473-endpoints-clinical-trials-cardiovascular-disorders.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd229182-immuno-chemistry-market-outlook-brics-brazil.html">
  <dc:language>en</dc:language>
  <dc:date>2012-01-16</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Immuno Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017</title>
  <link>http://www.giiresearch.com/report/gd229182-immuno-chemistry-market-outlook-brics-brazil.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd229184-microbiology-culture-market-outlook-brics-brazil.html">
  <dc:language>en</dc:language>
  <dc:date>2012-01-16</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Microbiology Culture Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017</title>
  <link>http://www.giiresearch.com/report/gd229184-microbiology-culture-market-outlook-brics-brazil.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc228043-tissue-engineering-regeneration-technologies.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:date>2012-01-10</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Tissue Engineering and Regeneration: Technologies and Global Markets</title>
  <link>http://www.giiresearch.com/report/bc228043-tissue-engineering-regeneration-technologies.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg166271-hematology-suppliers.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2012-01-09</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Leading Hematology and Flow Cytometry Market Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants</title>
  <link>http://www.giiresearch.com/report/vpg166271-hematology-suppliers.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd228217-genetic-testing-market-outlook-brics-brazil-russia.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2012-01-09</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017</title>
  <link>http://www.giiresearch.com/report/gd228217-genetic-testing-market-outlook-brics-brazil-russia.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd228218-histology-cytology-market-outlook-brics-brazil.html">
  <dc:language>en</dc:language>
  <dc:date>2012-01-09</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Histology And Cytology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017</title>
  <link>http://www.giiresearch.com/report/gd228218-histology-cytology-market-outlook-brics-brazil.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd228220-haematology-brics-market-outlook-brics-brazil.html">
  <dc:language>en</dc:language>
  <dc:date>2012-01-09</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Haematology in BRICS Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017</title>
  <link>http://www.giiresearch.com/report/gd228220-haematology-brics-market-outlook-brics-brazil.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg228246-future-japanese-hematology-flow-cytometry-markets.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2012-01-09</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future Japanese Hematology and Flow Cytometry Markets</title>
  <link>http://www.giiresearch.com/report/vpg228246-future-japanese-hematology-flow-cytometry-markets.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg228247-emerging-special-hematology-tests-flow-cytometry.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2012-01-09</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Emerging Special Hematology Tests and Flow Cytometry Applications</title>
  <link>http://www.giiresearch.com/report/vpg228247-emerging-special-hematology-tests-flow-cytometry.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs228004-analysis-stem-cell-markets-unlocking-new-era.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:date>2012-01-05</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Analysis of the Stem Cell Markets - Unlocking the New Era in Therapeutics</title>
  <link>http://www.giiresearch.com/report/fs228004-analysis-stem-cell-markets-unlocking-new-era.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/biof227599-strategic-development-neural-stem-progenitor-cell.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:date>2012-01-04</dc:date>
  <dc:creator>BioInformant</dc:creator>
  <title>Strategic Development of Neural Stem &amp; Progenitor Cell Products</title>
  <link>http://www.giiresearch.com/report/biof227599-strategic-development-neural-stem-progenitor-cell.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70915-diagnostics.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:date>2012-01-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Molecular Diagnostics - Technologies, Markets and Companies</title>
  <link>http://www.giiresearch.com/report/jai70915-diagnostics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70916-cell-therapy.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:date>2012-01-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Cell Therapy - Technologies, Markets and Companies</title>
  <link>http://www.giiresearch.com/report/jai70916-cell-therapy.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70918-proteomics.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:date>2012-01-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Proteomics - Technologies, Markets and Companies</title>
  <link>http://www.giiresearch.com/report/jai70918-proteomics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70919-neuroprotection.html">
  <dc:language>en</dc:language>
  <dc:subject>Neurodegenerative Disease</dc:subject>
  <dc:date>2012-01-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Neuroprotection - Drugs, Markets and Companies</title>
  <link>http://www.giiresearch.com/report/jai70919-neuroprotection.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70921-transdermal.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Delivery System</dc:subject>
  <dc:date>2012-01-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Transdermal Drug Delivery - Technologies, Markets, and Companies</title>
  <link>http://www.giiresearch.com/report/jai70921-transdermal.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70922-animal-bio.html">
  <dc:language>en</dc:language>
  <dc:subject>Veterinary Medicine</dc:subject>
  <dc:date>2012-01-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Animal Biotechnology - Technologies, Markets and Companies</title>
  <link>http://www.giiresearch.com/report/jai70922-animal-bio.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70924-medicine.html">
  <dc:language>en</dc:language>
  <dc:subject>Personalized Medicine</dc:subject>
  <dc:date>2012-01-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Personalized Medicine - scientific &amp; commercial aspects</title>
  <link>http://www.giiresearch.com/report/jai70924-medicine.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70928-drug-deli.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Delivery System</dc:subject>
  <dc:date>2012-01-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Drug Delivery in Cancer - technologies, markets and companies</title>
  <link>http://www.giiresearch.com/report/jai70928-drug-deli.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70930-rnai.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:date>2012-01-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>RNAi - technologies, markets and companies</title>
  <link>http://www.giiresearch.com/report/jai70930-rnai.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70931-gene-therapy.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:date>2012-01-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Gene Therapy - technologies, markets and companies</title>
  <link>http://www.giiresearch.com/report/jai70931-gene-therapy.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70933-nanobio.html">
  <dc:language>en</dc:language>
  <dc:subject>Nanotechnology</dc:subject>
  <dc:date>2012-01-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Nanobiotechnologies- applications, markets and companies</title>
  <link>http://www.giiresearch.com/report/jai70933-nanobio.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70934-central-nervous.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Delivery System</dc:subject>
  <dc:subject>Neurodegenerative Disease</dc:subject>
  <dc:date>2012-01-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Drug Delivery in Central Nervous System Diseases - technologies, markets and companies</title>
  <link>http://www.giiresearch.com/report/jai70934-central-nervous.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70936-cardiovascular.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Delivery System</dc:subject>
  <dc:date>2012-01-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Cardiovascular Drug Delivery - technologies,markets and companies</title>
  <link>http://www.giiresearch.com/report/jai70936-cardiovascular.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70937-biomarkers.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>In Vitro Diagnostics Equipment</dc:subject>
  <dc:date>2012-01-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Biomarkers - technologies,markets and companies</title>
  <link>http://www.giiresearch.com/report/jai70937-biomarkers.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70938-cytogenetics.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>In Vitro Diagnostics Equipment</dc:subject>
  <dc:date>2012-01-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Cytogenetics - technologies,markets and companies</title>
  <link>http://www.giiresearch.com/report/jai70938-cytogenetics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70939-therapeutics.html">
  <dc:language>en</dc:language>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:date>2012-01-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Antiviral Therapeutics - technologies, markets and companies</title>
  <link>http://www.giiresearch.com/report/jai70939-therapeutics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai84243-dna-sequ-tech.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:date>2012-01-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>DNA sequencing: technologies, markets and companies</title>
  <link>http://www.giiresearch.com/report/jai84243-dna-sequ-tech.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai136243-biochips.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2012-01-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Biochips - technologies,markets and companies</title>
  <link>http://www.giiresearch.com/report/jai136243-biochips.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc224399-2011-biotechnology-research-review.html">
  <dc:language>en</dc:language>
  <dc:date>2012-01-01</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>2011 Biotechnology Research Review</title>
  <link>http://www.giiresearch.com/report/bc224399-2011-biotechnology-research-review.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kl227816-stem-cells-worldwide-markets-transplantation-cord.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:date>2012-01-01</dc:date>
  <dc:creator>Kalorama Information</dc:creator>
  <title>Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development</title>
  <link>http://www.giiresearch.com/report/kl227816-stem-cells-worldwide-markets-transplantation-cord.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/ida227848-us-market-dental-bone-graft-substitutes-dental.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomaterials</dc:subject>
  <dc:date>2012-01-01</dc:date>
  <dc:creator>iData Research Inc.</dc:creator>
  <title>U.S. Market for Dental Bone Graft Substitutes, Dental Membranes and Tissue Engineering Products 2012</title>
  <link>http://www.giiresearch.com/report/ida227848-us-market-dental-bone-graft-substitutes-dental.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/cd228355-high-content-analysis-technologies-applications.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-31</dc:date>
  <dc:creator>Insight Pharma Reports</dc:creator>
  <title>High-Content Analysis: Technologies, Applications, and Market Dynamics</title>
  <link>http://www.giiresearch.com/report/cd228355-high-content-analysis-technologies-applications.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg194071-triple-analysis-leukemia-apoptosis-antibodies.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2011-12-30</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Leukemia, Apoptosis and Antibodies</title>
  <link>http://www.giiresearch.com/report/bg194071-triple-analysis-leukemia-apoptosis-antibodies.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/ti228447-nucleic-acid-based-therapeutics.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:date>2011-12-30</dc:date>
  <dc:creator>Technical Insights, Inc.</dc:creator>
  <title>Nucleic-Acid Based Therapeutics</title>
  <link>http://www.giiresearch.com/report/ti228447-nucleic-acid-based-therapeutics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/mrg227374-european-markets-orthopedic-biomaterials-2012.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomaterials</dc:subject>
  <dc:subject>Orthopedic</dc:subject>
  <dc:date>2011-12-29</dc:date>
  <dc:creator>Millennium Research Group</dc:creator>
  <title>European Markets for Orthopedic Biomaterials 2012</title>
  <link>http://www.giiresearch.com/report/mrg227374-european-markets-orthopedic-biomaterials-2012.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/mrg227375-asia-pacific-markets-orthopedic-biomaterials.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomaterials</dc:subject>
  <dc:subject>Orthopedic</dc:subject>
  <dc:date>2011-12-29</dc:date>
  <dc:creator>Millennium Research Group</dc:creator>
  <title>Asia Pacific Markets for Orthopedic Biomaterials</title>
  <link>http://www.giiresearch.com/report/mrg227375-asia-pacific-markets-orthopedic-biomaterials.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs227473-european-molecular-diagnostics-markets.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>In Vitro Diagnostics Equipment</dc:subject>
  <dc:date>2011-12-28</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>European Molecular Diagnostics Markets</title>
  <link>http://www.giiresearch.com/report/fs227473-european-molecular-diagnostics-markets.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs227461-strategic-analysis-european-stem-cell-research.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-27</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Strategic Analysis of the European Stem Cell Research Tools Market</title>
  <link>http://www.giiresearch.com/report/fs227461-strategic-analysis-european-stem-cell-research.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs226614-analysis-european-biosimilars-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-12-20</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Analysis of European Biosimilars Market</title>
  <link>http://www.giiresearch.com/report/fs226614-analysis-european-biosimilars-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs226617-strategic-analysis-collagen-peptide-market-united.html">
  <dc:language>en</dc:language>
  <dc:date>2011-12-20</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Strategic Analysis of the Collagen Peptide Market in the United States</title>
  <link>http://www.giiresearch.com/report/fs226617-strategic-analysis-collagen-peptide-market-united.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs228274-frost-sullivan-2011-survey-sequencing-technologies.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-20</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Frost &amp; Sullivan 2011 Survey of Sequencing Technologies: Instrument Adoption on the Rise as Affordable Systems Enter the Market</title>
  <link>http://www.giiresearch.com/report/fs228274-frost-sullivan-2011-survey-sequencing-technologies.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg177473-col-cancer-apo-antibo.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2011-12-19</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Colorectal Cancer, Apoptosis and Antibodies</title>
  <link>http://www.giiresearch.com/report/bg177473-col-cancer-apo-antibo.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg195939-triple-analysis-lymphoma-apoptosis-antibodies.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2011-12-19</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Lymphoma, Apoptosis and Antibodies</title>
  <link>http://www.giiresearch.com/report/bg195939-triple-analysis-lymphoma-apoptosis-antibodies.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg207065-triple-analysis-breast-cancer-lung-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2011-12-19</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Breast Cancer, Lung Cancer and Apoptosis</title>
  <link>http://www.giiresearch.com/report/bg207065-triple-analysis-breast-cancer-lung-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg207613-triple-analysis-lung-cancer-apoptosis-antibodies.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2011-12-19</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Lung Cancer, Apoptosis and Antibodies</title>
  <link>http://www.giiresearch.com/report/bg207613-triple-analysis-lung-cancer-apoptosis-antibodies.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg216996-triple-analysis-apoptosis-antibodies-peptides.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2011-12-19</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Apoptosis, Antibodies and Peptides</title>
  <link>http://www.giiresearch.com/report/bg216996-triple-analysis-apoptosis-antibodies-peptides.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg216997-triple-analysis-apoptosis-cancer-vaccines.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Vaccines</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2011-12-19</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Apoptosis, Cancer Vaccines and Antibodies</title>
  <link>http://www.giiresearch.com/report/bg216997-triple-analysis-apoptosis-cancer-vaccines.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg216998-triple-analysis-apoptosis-protein-kinase.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2011-12-19</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Apoptosis, Protein Kinase Inhibitors and Antibodies</title>
  <link>http://www.giiresearch.com/report/bg216998-triple-analysis-apoptosis-protein-kinase.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg217001-triple-analysis-breast-cancer-apoptosis-antibodies.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2011-12-19</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Breast Cancer, Apoptosis and Antibodies</title>
  <link>http://www.giiresearch.com/report/bg217001-triple-analysis-breast-cancer-apoptosis-antibodies.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg217015-triple-analysis-melanoma-apoptosis-antibodies.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2011-12-19</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Melanoma, Apoptosis and Antibodies</title>
  <link>http://www.giiresearch.com/report/bg217015-triple-analysis-melanoma-apoptosis-antibodies.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg217023-triple-analysis-pancreatic-cancer-apoptosis.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2011-12-19</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Pancreatic Cancer, Apoptosis and Antibodies</title>
  <link>http://www.giiresearch.com/report/bg217023-triple-analysis-pancreatic-cancer-apoptosis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg217037-triple-analysis-prostate-cancer-apoptosis.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2011-12-19</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Prostate Cancer, Apoptosis and Antibodies</title>
  <link>http://www.giiresearch.com/report/bg217037-triple-analysis-prostate-cancer-apoptosis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg227316-analytical-tool-apoptosis-oncology.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2011-12-19</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Apoptosis in Oncology</title>
  <link>http://www.giiresearch.com/report/bg227316-analytical-tool-apoptosis-oncology.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fuji225702-stem-cells-regenerative-medicine-benchmarking.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:date>2011-12-15</dc:date>
  <dc:creator>Fuji-Keizai U.S.A., Inc.</dc:creator>
  <title>Stem Cells in Regenerative Medicine - Benchmarking Analysis of Big Companies Entering the Market</title>
  <link>http://www.giiresearch.com/report/fuji225702-stem-cells-regenerative-medicine-benchmarking.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs226599-european-pharmaceutical-biotech-contract.html">
  <dc:language>en</dc:language>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:date>2011-12-15</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>European Pharmaceutical and Biotech Contract Manufacturing Markets</title>
  <link>http://www.giiresearch.com/report/fs226599-european-pharmaceutical-biotech-contract.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kt229862-biobanking-medicine-technology-market-2012-2022.html">
  <dc:language>en</dc:language>
  <dc:date>2011-12-13</dc:date>
  <dc:creator>Visiongain</dc:creator>
  <title>Biobanking for Medicine: Technology and Market 2012-2022</title>
  <link>http://www.giiresearch.com/report/kt229862-biobanking-medicine-technology-market-2012-2022.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs228271-specialty-physicians-discuss-their-opinions-united.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-12-08</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Specialty Physicians Discuss their Opinions of the United States Biosimilars Market</title>
  <link>http://www.giiresearch.com/report/fs228271-specialty-physicians-discuss-their-opinions-united.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc229460-hot-topics-impact-biomarkers-alzheimers-disease-dx.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Neurodegenerative Disease</dc:subject>
  <dc:date>2011-12-02</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Hot Topics: Impact of Biomarkers in Alzheimer's Disease - Dx-Rx collaboration paves the way for personalized medicine</title>
  <link>http://www.giiresearch.com/report/dc229460-hot-topics-impact-biomarkers-alzheimers-disease-dx.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg166145-emerging-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>In Vitro Diagnostics Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Emerging Cancer Diagnostic Tests and Companies Developing New Technologies</title>
  <link>http://www.giiresearch.com/report/vpg166145-emerging-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg166199-laboratory-poc.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Global Overview of the Laboratory and POC Coagulation Testing Markets: Facilities, Test Volumes, Sales Forecasts, and Key Player Market Shares</title>
  <link>http://www.giiresearch.com/report/vpg166199-laboratory-poc.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg223934-future-coagulation-testing-market-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future Coagulation Testing Market: Growth Opportunities and Business Expansion Strategies</title>
  <link>http://www.giiresearch.com/report/vpg223934-future-coagulation-testing-market-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi224312-monoclonal-antibodies-market-2017-multiple.html">
  <dc:language>en</dc:language>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market</title>
  <link>http://www.giiresearch.com/report/gbi224312-monoclonal-antibodies-market-2017-multiple.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg225022-global-beta-2-microglobulin-testing-market-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Global Beta-2 Microglobulin Testing Market: Growth Opportunities and Strategies</title>
  <link>http://www.giiresearch.com/report/vpg225022-global-beta-2-microglobulin-testing-market-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg225023-global-ca-tumor-markers-growth-opportunities.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Global CA Tumor Markers: Growth Opportunities and Strategies</title>
  <link>http://www.giiresearch.com/report/vpg225023-global-ca-tumor-markers-growth-opportunities.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg225024-global-cea-testing-market-growth-opportunities.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Global CEA Testing Market: Growth Opportunities and Strategies</title>
  <link>http://www.giiresearch.com/report/vpg225024-global-cea-testing-market-growth-opportunities.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg225025-global-occult-blood-testing-market-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Global Occult Blood Testing Market: Growth Opportunities and Strategies</title>
  <link>http://www.giiresearch.com/report/vpg225025-global-occult-blood-testing-market-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg225026-global-prostatic-acid-phosphatase-testing-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Global Prostatic Acid Phosphatase Testing Market: Growth Opportunities and Strategies</title>
  <link>http://www.giiresearch.com/report/vpg225026-global-prostatic-acid-phosphatase-testing-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg225027-global-pap-smear-hpv-testing-market-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Global Pap Smear/HPV Testing Market: Growth Opportunities and Strategies</title>
  <link>http://www.giiresearch.com/report/vpg225027-global-pap-smear-hpv-testing-market-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg225028-global-psa-testing-market-growth-opportunities.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Global PSA Testing Market: Growth Opportunities and Strategies</title>
  <link>http://www.giiresearch.com/report/vpg225028-global-psa-testing-market-growth-opportunities.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg225029-future-cell-surface-markers-us-europe-japan.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future Cell Surface Markers: US, Europe, Japan</title>
  <link>http://www.giiresearch.com/report/vpg225029-future-cell-surface-markers-us-europe-japan.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg225030-future-clinical-chemistry-immunodiagnostics.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future Clinical Chemistry and Immunodiagnostics Markets: Facilities, Test Volumes, and Sales Forecasts by Country</title>
  <link>http://www.giiresearch.com/report/vpg225030-future-clinical-chemistry-immunodiagnostics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg225031-future-clinical-chemistry-market-us-europe-japan.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future Clinical Chemistry Market: US, Europe, Japan</title>
  <link>http://www.giiresearch.com/report/vpg225031-future-clinical-chemistry-market-us-europe-japan.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg225034-future-immunoprotein-diagnostics-market-us-europe.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future Immunoprotein Diagnostics Market: US, Europe, Japan</title>
  <link>http://www.giiresearch.com/report/vpg225034-future-immunoprotein-diagnostics-market-us-europe.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg225035-world-clinical-chemistry-immunodiagnostics-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>World Clinical Chemistry and Immunodiagnostics Market Key Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants</title>
  <link>http://www.giiresearch.com/report/vpg225035-world-clinical-chemistry-immunodiagnostics-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg225036-emerging-chemistry-immunodiagnostic-tests.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Emerging Chemistry and Immunodiagnostic Tests and Companies Developing New Technologies</title>
  <link>http://www.giiresearch.com/report/vpg225036-emerging-chemistry-immunodiagnostic-tests.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg225038-emerging-clinical-chemistry-immunodiagnostic.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Emerging Clinical Chemistry And Immunodiagnostic Technologies</title>
  <link>http://www.giiresearch.com/report/vpg225038-emerging-clinical-chemistry-immunodiagnostic.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg225039-emerging-coagulation-testing-technologies-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Emerging Coagulation Testing Technologies and Market Applications</title>
  <link>http://www.giiresearch.com/report/vpg225039-emerging-coagulation-testing-technologies-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg225040-world-coagulation-market-key-players-strategic.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>World Coagulation Market Key Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants</title>
  <link>http://www.giiresearch.com/report/vpg225040-world-coagulation-market-key-players-strategic.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg225041-emerging-coagulation-tests-suppliers-developing.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Emerging Coagulation Tests and Suppliers Developing New Technologies</title>
  <link>http://www.giiresearch.com/report/vpg225041-emerging-coagulation-tests-suppliers-developing.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg225051-world-molecular-diagnostics-market-facilities-test.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>World Molecular Diagnostics Market: Facilities, Test Volumes, and Sales Forecasts by Country</title>
  <link>http://www.giiresearch.com/report/vpg225051-world-molecular-diagnostics-market-facilities-test.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg225052-emerging-cancer-molecular-diagnostic-tests.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Emerging Cancer Molecular Diagnostic Tests</title>
  <link>http://www.giiresearch.com/report/vpg225052-emerging-cancer-molecular-diagnostic-tests.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg225053-world-molecular-diagnostics-market-key-players.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>World Molecular Diagnostics Market Key Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants</title>
  <link>http://www.giiresearch.com/report/vpg225053-world-molecular-diagnostics-market-key-players.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg225054-emerging-molecular-diagnostic-applications.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Emerging Molecular Diagnostic Applications: Forensics, Paternity, Disease Susceptibility</title>
  <link>http://www.giiresearch.com/report/vpg225054-emerging-molecular-diagnostic-applications.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg225055-world-molecular-diagnostics-market-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>World Molecular Diagnostics Market: Growth Opportunities, Business Expansion Strategies, Entry Barriers and Risks</title>
  <link>http://www.giiresearch.com/report/vpg225055-world-molecular-diagnostics-market-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/rnc226592-global-mirna-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:date>2011-12-01</dc:date>
  <dc:creator>RNCOS E-Services Pvt. Ltd.</dc:creator>
  <title>Global miRNA Market Outlook</title>
  <link>http://www.giiresearch.com/report/rnc226592-global-mirna-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/mrg225459-us-markets-orthopedic-biomaterials-2012.html">
  <dc:language>en</dc:language>
  <dc:subject>Orthopedic</dc:subject>
  <dc:subject>Biomaterials</dc:subject>
  <dc:date>2011-11-30</dc:date>
  <dc:creator>Millennium Research Group</dc:creator>
  <title>US Markets for Orthopedic Biomaterials 2012</title>
  <link>http://www.giiresearch.com/report/mrg225459-us-markets-orthopedic-biomaterials-2012.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/mrg225463-us-markets-surgical-hemostats-internal-tissue.html">
  <dc:language>en</dc:language>
  <dc:subject>Wound Care</dc:subject>
  <dc:date>2011-11-30</dc:date>
  <dc:creator>Millennium Research Group</dc:creator>
  <title>US Markets for Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers 2012</title>
  <link>http://www.giiresearch.com/report/mrg225463-us-markets-surgical-hemostats-internal-tissue.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/rb228156-innovations-molecular-diagnostics-infectious.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:date>2011-11-30</dc:date>
  <dc:creator>Business Insights</dc:creator>
  <title>Innovations in Molecular Diagnostics for Infectious Diseases</title>
  <link>http://www.giiresearch.com/report/rb228156-innovations-molecular-diagnostics-infectious.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs224904-outlook-european-market-bioactive-collagen-peptide.html">
  <dc:language>en</dc:language>
  <dc:date>2011-11-29</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>The Outlook of the European Market for Bioactive Collagen Peptide</title>
  <link>http://www.giiresearch.com/report/fs224904-outlook-european-market-bioactive-collagen-peptide.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc224398-synthetic-biology-emerging-global-markets.html">
  <dc:language>en</dc:language>
  <dc:date>2011-11-28</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Synthetic Biology: Emerging Global Markets</title>
  <link>http://www.giiresearch.com/report/bc224398-synthetic-biology-emerging-global-markets.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224788-future-french-clinical-chemistry-immunodiagnostics.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-11-28</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future French Clinical Chemistry and Immunodiagnostics Markets: Growth Opportunities and Business Expansion Strategies</title>
  <link>http://www.giiresearch.com/report/vpg224788-future-french-clinical-chemistry-immunodiagnostics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224789-future-german-clinical-chemistry-immunodiagnostics.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-11-28</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future German Clinical Chemistry and Immunodiagnostics Markets: Growth Opportunities and Business Expansion Strategies</title>
  <link>http://www.giiresearch.com/report/vpg224789-future-german-clinical-chemistry-immunodiagnostics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224790-future-italian-clinical-chemistry.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-11-28</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future Italian Clinical Chemistry and Immunodiagnostics Markets: Growth Opportunities and Business Expansion Strategies</title>
  <link>http://www.giiresearch.com/report/vpg224790-future-italian-clinical-chemistry.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224791-future-japanese-clinical-chemistry.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-11-28</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future Japanese Clinical Chemistry and Immunodiagnostics Markets: Growth Opportunities and Business Expansion Strategies</title>
  <link>http://www.giiresearch.com/report/vpg224791-future-japanese-clinical-chemistry.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224792-future-spanish-clinical-chemistry.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-11-28</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future Spanish Clinical Chemistry and Immunodiagnostics Markets: Growth Opportunities and Business Expansion Strategies</title>
  <link>http://www.giiresearch.com/report/vpg224792-future-spanish-clinical-chemistry.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224793-future-uk-clinical-chemistry-immunodiagnostics.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-11-28</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future UK Clinical Chemistry and Immunodiagnostics Markets: Growth Opportunities and Business Expansion Strategies</title>
  <link>http://www.giiresearch.com/report/vpg224793-future-uk-clinical-chemistry-immunodiagnostics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224794-future-us-clinical-chemistry-immunodiagnostics.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-11-28</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future US Clinical Chemistry and Immunodiagnostics Markets: Growth Opportunities and Business Expansion Strategies</title>
  <link>http://www.giiresearch.com/report/vpg224794-future-us-clinical-chemistry-immunodiagnostics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224795-future-french-coagulation-market-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-11-28</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future French Coagulation Market: Growth Opportunities and Business Expansion Strategies</title>
  <link>http://www.giiresearch.com/report/vpg224795-future-french-coagulation-market-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224796-future-german-coagulation-market-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-11-28</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future German Coagulation Market: Growth Opportunities and Business Expansion Strategies</title>
  <link>http://www.giiresearch.com/report/vpg224796-future-german-coagulation-market-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224797-future-italian-coagulation-marke-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-11-28</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future Italian Coagulation Marke: Growth Opportunities and Business Expansion Strategiest</title>
  <link>http://www.giiresearch.com/report/vpg224797-future-italian-coagulation-marke-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224798-future-japanese-coagulation-market-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-11-28</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future Japanese Coagulation Market: Growth Opportunities and Business Expansion Strategies</title>
  <link>http://www.giiresearch.com/report/vpg224798-future-japanese-coagulation-market-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224799-future-spanish-coagulation-market-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-11-28</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future Spanish Coagulation Market: Growth Opportunities and Business Expansion Strategies</title>
  <link>http://www.giiresearch.com/report/vpg224799-future-spanish-coagulation-market-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224800-future-uk-coagulation-market-growth-opportunities.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-11-28</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future UK Coagulation Market: Growth Opportunities and Business Expansion Strategies</title>
  <link>http://www.giiresearch.com/report/vpg224800-future-uk-coagulation-market-growth-opportunities.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224801-future-us-coagulation-market-growth-opportunities.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-11-28</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future US Coagulation Market: Growth Opportunities and Business Expansion Strategies</title>
  <link>http://www.giiresearch.com/report/vpg224801-future-us-coagulation-market-growth-opportunities.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224809-future-french-molecular-diagnostics-market-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-11-28</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future French Molecular Diagnostics Market: Growth Opportunities and Business Expansion Strategies</title>
  <link>http://www.giiresearch.com/report/vpg224809-future-french-molecular-diagnostics-market-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224810-future-german-molecular-diagnostics-market-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-11-28</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future German Molecular Diagnostics Market: Growth Opportunities and Business Expansion Strategies</title>
  <link>http://www.giiresearch.com/report/vpg224810-future-german-molecular-diagnostics-market-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224811-future-italian-molecular-diagnostics-market-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-11-28</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future Italian Molecular Diagnostics Market: Growth Opportunities and Business Expansion Strategies</title>
  <link>http://www.giiresearch.com/report/vpg224811-future-italian-molecular-diagnostics-market-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224812-future-japanese-molecular-diagnostics-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-11-28</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future Japanese Molecular Diagnostics Market: Growth Opportunities and Business Expansion Strategies</title>
  <link>http://www.giiresearch.com/report/vpg224812-future-japanese-molecular-diagnostics-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224813-future-spanish-molecular-diagnostics-market-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-11-28</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future Spanish Molecular Diagnostics Market: Growth Opportunities and Business Expansion Strategies</title>
  <link>http://www.giiresearch.com/report/vpg224813-future-spanish-molecular-diagnostics-market-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224814-future-uk-molecular-diagnostics-market-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-11-28</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future UK Molecular Diagnostics Market: Growth Opportunities and Business Expansion Strategies</title>
  <link>http://www.giiresearch.com/report/vpg224814-future-uk-molecular-diagnostics-market-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg224815-future-us-molecular-diagnostics-market-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-11-28</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Future US Molecular Diagnostics Market: Growth Opportunities and Business Expansion Strategies</title>
  <link>http://www.giiresearch.com/report/vpg224815-future-us-molecular-diagnostics-market-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc229453-emerging-technologies-stem-cells.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:date>2011-11-28</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Emerging Technologies: Stem cells</title>
  <link>http://www.giiresearch.com/report/dc229453-emerging-technologies-stem-cells.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs224898-strategic-analysis-us-next-generation-sequencing.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:date>2011-11-23</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Strategic Analysis of the U.S. Next-Generation Sequencing Services Market</title>
  <link>http://www.giiresearch.com/report/fs224898-strategic-analysis-us-next-generation-sequencing.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi224311-stem-cell-research-market-2017-strong-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:date>2011-11-22</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Stem Cell Research Market to 2017 - Strong Pipeline, High Unmet Needs in Chronic Diseases and Favorable Government Policies to Boost Stem Cell R&amp;D</title>
  <link>http://www.giiresearch.com/report/gbi224311-stem-cell-research-market-2017-strong-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/lmer224082-competitor-analysis-anti-infective-antibodies.html">
  <dc:language>en</dc:language>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:date>2011-11-21</dc:date>
  <dc:creator>La Merie Publishing</dc:creator>
  <title>Competitor Analysis: Anti-Infective Antibodies</title>
  <link>http://www.giiresearch.com/report/lmer224082-competitor-analysis-anti-infective-antibodies.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc229444-biotech-company-outlook-2016.html">
  <dc:language>en</dc:language>
  <dc:date>2011-11-18</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Biotech Company Outlook to 2016</title>
  <link>http://www.giiresearch.com/report/dc229444-biotech-company-outlook-2016.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/arm223423-polymerase-chain-reaction-pcr-products-tools.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:date>2011-11-15</dc:date>
  <dc:creator>Axis Research Mind</dc:creator>
  <title>Polymerase Chain Reaction (PCR) - Products/Tools - A Global Market Watch, 2009-2015</title>
  <link>http://www.giiresearch.com/report/arm223423-polymerase-chain-reaction-pcr-products-tools.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/arm223424-polymerase-chain-reaction-pcr-medical-application.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:date>2011-11-15</dc:date>
  <dc:creator>Axis Research Mind</dc:creator>
  <title>Polymerase Chain Reaction (PCR) In Medical Application - An Analytical Report, 2009-2015</title>
  <link>http://www.giiresearch.com/report/arm223424-polymerase-chain-reaction-pcr-medical-application.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166026-antibodi-pepti-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2011-11-14</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Antibodies and Peptides in Oncology</title>
  <link>http://www.giiresearch.com/report/bg166026-antibodi-pepti-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166078-peptides-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2011-11-14</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Peptides in Oncology</title>
  <link>http://www.giiresearch.com/report/bg166078-peptides-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg177486-col-cancer-antibo-pepti.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2011-11-14</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Colorectal Cancer, Antibodies and Peptides</title>
  <link>http://www.giiresearch.com/report/bg177486-col-cancer-antibo-pepti.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg194069-triple-analysis-leukemia-antibodies-peptides.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2011-11-14</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Leukemia, Antibodies and Peptides</title>
  <link>http://www.giiresearch.com/report/bg194069-triple-analysis-leukemia-antibodies-peptides.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg195951-triple-analysis-lymphoma-antibodies-peptides.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2011-11-14</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Lymphoma, Antibodies and Peptides</title>
  <link>http://www.giiresearch.com/report/bg195951-triple-analysis-lymphoma-antibodies-peptides.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg207639-triple-analysis-lung-cancer-antibodies-peptides.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2011-11-14</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Lung Cancer, Antibodies and Peptides</title>
  <link>http://www.giiresearch.com/report/bg207639-triple-analysis-lung-cancer-antibodies-peptides.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg217000-triple-analysis-breast-cancer-antibodies-peptides.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2011-11-14</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Breast Cancer, Antibodies and Peptides</title>
  <link>http://www.giiresearch.com/report/bg217000-triple-analysis-breast-cancer-antibodies-peptides.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg217007-triple-analysis-cancer-vaccines-antibodies.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Vaccines</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2011-11-14</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Cancer Vaccines, Antibodies and Peptides</title>
  <link>http://www.giiresearch.com/report/bg217007-triple-analysis-cancer-vaccines-antibodies.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg217013-triple-analysis-melanoma-antibodies-peptides.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2011-11-14</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Melanoma, Antibodies and Peptides</title>
  <link>http://www.giiresearch.com/report/bg217013-triple-analysis-melanoma-antibodies-peptides.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg217022-triple-analysis-pancreatic-cancer-antibodies.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2011-11-14</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Pancreatic Cancer, Antibodies and Peptides</title>
  <link>http://www.giiresearch.com/report/bg217022-triple-analysis-pancreatic-cancer-antibodies.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg217036-triple-analysis-prostate-cancer-antibodies.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2011-11-14</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Prostate Cancer, Antibodies and Peptides</title>
  <link>http://www.giiresearch.com/report/bg217036-triple-analysis-prostate-cancer-antibodies.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg217040-triple-analysis-protein-kinase-inhibitors.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2011-11-14</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Triple Analysis: Protein Kinase Inhibitors, Antibodies and Peptides</title>
  <link>http://www.giiresearch.com/report/bg217040-triple-analysis-protein-kinase-inhibitors.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/ren223412-genetic-testing-market-forecast-global-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-11-14</dc:date>
  <dc:creator>Renub Research</dc:creator>
  <title>Genetic Testing Market and Forecast - Global Analysis 2010 - 2015</title>
  <link>http://www.giiresearch.com/report/ren223412-genetic-testing-market-forecast-global-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg224089-commercializing-peptides-cancer-faster-route.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2011-11-14</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Commercializing Peptides in Cancer: The Faster Route to Consider Your Options and Position of Others</title>
  <link>http://www.giiresearch.com/report/bg224089-commercializing-peptides-cancer-faster-route.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/biof223139-stem-cell-research-products-opportunities-tools.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-11-11</dc:date>
  <dc:creator>BioInformant</dc:creator>
  <title>Stem Cell Research Products - Opportunities, Tools, and Technologies</title>
  <link>http://www.giiresearch.com/report/biof223139-stem-cell-research-products-opportunities-tools.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dgpl222810-biosimilar-drugs-europe-threat-or-opportunity.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-11-08</dc:date>
  <dc:creator>Doctor's Guide Publishing Limited (FirstWord Pharma)</dc:creator>
  <title>Biosimilar Drugs in Europe: threat or opportunity to innovation?</title>
  <link>http://www.giiresearch.com/report/dgpl222810-biosimilar-drugs-europe-threat-or-opportunity.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/mrg223062-us-markets-soft-tissue-repair-devices-2012.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:subject>Orthopedic</dc:subject>
  <dc:date>2011-11-08</dc:date>
  <dc:creator>Millennium Research Group</dc:creator>
  <title>US Markets for Soft Tissue Repair Devices 2012</title>
  <link>http://www.giiresearch.com/report/mrg223062-us-markets-soft-tissue-repair-devices-2012.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kt226943-next-generation-antibody-therapies-pipeline-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Antibody &amp; Immunity</dc:subject>
  <dc:date>2011-11-08</dc:date>
  <dc:creator>Visiongain</dc:creator>
  <title>Next-Generation Antibody Therapies: Pipeline and Market 2011-2021</title>
  <link>http://www.giiresearch.com/report/kt226943-next-generation-antibody-therapies-pipeline-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/arm222464-biorepositories-equipments-applications.html">
  <dc:language>en</dc:language>
  <dc:date>2011-11-07</dc:date>
  <dc:creator>Axis Research Mind</dc:creator>
  <title>BIOREPOSITORIES: EQUIPMENTS, APPLICATIONS, TECHNOLOGIES, OWNERSHIP AND END-USERS - AN ANALYTICAL REPORT, 2009-2015</title>
  <link>http://www.giiresearch.com/report/arm222464-biorepositories-equipments-applications.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/arm222466-biorepositories-equipments-applications-global.html">
  <dc:language>en</dc:language>
  <dc:date>2011-11-07</dc:date>
  <dc:creator>Axis Research Mind</dc:creator>
  <title>BIOREPOSITORIES: EQUIPMENTS &amp; APPLICATIONS - A GLOBAL MARKET WATCH, 2009-2015</title>
  <link>http://www.giiresearch.com/report/arm222466-biorepositories-equipments-applications-global.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/arm222467-biorepositories-equipments-technologies-global.html">
  <dc:language>en</dc:language>
  <dc:date>2011-11-07</dc:date>
  <dc:creator>Axis Research Mind</dc:creator>
  <title>BIOREPOSITORIES: EQUIPMENTS &amp; TECHNOLOGIES - A GLOBAL MARKET WATCH, 2009-2015</title>
  <link>http://www.giiresearch.com/report/arm222467-biorepositories-equipments-technologies-global.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/arm222468-biorepositories-applications-technologies-global.html">
  <dc:language>en</dc:language>
  <dc:date>2011-11-07</dc:date>
  <dc:creator>Axis Research Mind</dc:creator>
  <title>BIOREPOSITORIES: APPLICATIONS &amp; TECHNOLOGIES - A GLOBAL MARKET WATCH, 2009-2015</title>
  <link>http://www.giiresearch.com/report/arm222468-biorepositories-applications-technologies-global.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/arm222469-biorepositories-applications-end-users-global.html">
  <dc:language>en</dc:language>
  <dc:date>2011-11-07</dc:date>
  <dc:creator>Axis Research Mind</dc:creator>
  <title>BIOREPOSITORIES: APPLICATIONS &amp; END-USERS - A GLOBAL MARKET WATCH, 2009-2015</title>
  <link>http://www.giiresearch.com/report/arm222469-biorepositories-applications-end-users-global.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/arm222471-biorepositories-technologies-end-users-global.html">
  <dc:language>en</dc:language>
  <dc:date>2011-11-07</dc:date>
  <dc:creator>Axis Research Mind</dc:creator>
  <title>BIOREPOSITORIES: TECHNOLOGIES &amp; END-USERS - A GLOBAL MARKET WATCH, 2009-2015</title>
  <link>http://www.giiresearch.com/report/arm222471-biorepositories-technologies-end-users-global.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/arm222472-biorepositories-applications-ownership-global.html">
  <dc:language>en</dc:language>
  <dc:date>2011-11-07</dc:date>
  <dc:creator>Axis Research Mind</dc:creator>
  <title>BIOREPOSITORIES: APPLICATIONS &amp; OWNERSHIP - A GLOBAL MARKET WATCH, 2009-2015</title>
  <link>http://www.giiresearch.com/report/arm222472-biorepositories-applications-ownership-global.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/arm222473-biorepositories-technologies-ownership-global.html">
  <dc:language>en</dc:language>
  <dc:date>2011-11-07</dc:date>
  <dc:creator>Axis Research Mind</dc:creator>
  <title>BIOREPOSITORIES: TECHNOLOGIES &amp; OWNERSHIP - A GLOBAL MARKET WATCH, 2009-2015</title>
  <link>http://www.giiresearch.com/report/arm222473-biorepositories-technologies-ownership-global.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/arm222474-biorepositories-equipments-ownership-global-market.html">
  <dc:language>en</dc:language>
  <dc:date>2011-11-07</dc:date>
  <dc:creator>Axis Research Mind</dc:creator>
  <title>BIOREPOSITORIES: EQUIPMENTS &amp; OWNERSHIP - A GLOBAL MARKET WATCH, 2009-2015</title>
  <link>http://www.giiresearch.com/report/arm222474-biorepositories-equipments-ownership-global-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/arm222811-biorepositories-ownership-end-users-global-market.html">
  <dc:language>en</dc:language>
  <dc:date>2011-11-07</dc:date>
  <dc:creator>Axis Research Mind</dc:creator>
  <title>BIOREPOSITORIES: OWNERSHIP &amp; END-USERS - A GLOBAL MARKET WATCH, 2009-2015</title>
  <link>http://www.giiresearch.com/report/arm222811-biorepositories-ownership-end-users-global-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/arm222812-biobanking-applications-global-market-watch-2009.html">
  <dc:language>en</dc:language>
  <dc:date>2011-11-07</dc:date>
  <dc:creator>Axis Research Mind</dc:creator>
  <title>BIOBANKING: APPLICATIONS - A GLOBAL MARKET WATCH, 2009-2015</title>
  <link>http://www.giiresearch.com/report/arm222812-biobanking-applications-global-market-watch-2009.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/arm222813-biobanking-technologies-global-market-watch-2009.html">
  <dc:language>en</dc:language>
  <dc:date>2011-11-07</dc:date>
  <dc:creator>Axis Research Mind</dc:creator>
  <title>BIOBANKING: TECHNOLOGIES - A GLOBAL MARKET WATCH, 2009-2015</title>
  <link>http://www.giiresearch.com/report/arm222813-biobanking-technologies-global-market-watch-2009.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/arm222814-biobanking-equipments-global-market-watch-2009.html">
  <dc:language>en</dc:language>
  <dc:date>2011-11-07</dc:date>
  <dc:creator>Axis Research Mind</dc:creator>
  <title>BIOBANKING: EQUIPMENTS - A GLOBAL MARKET WATCH, 2009-2015</title>
  <link>http://www.giiresearch.com/report/arm222814-biobanking-equipments-global-market-watch-2009.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/arm222816-biobanking-ownership-global-market-watch-2009-2015.html">
  <dc:language>en</dc:language>
  <dc:date>2011-11-07</dc:date>
  <dc:creator>Axis Research Mind</dc:creator>
  <title>BIOBANKING: OWNERSHIP - A GLOBAL MARKET WATCH, 2009-2015</title>
  <link>http://www.giiresearch.com/report/arm222816-biobanking-ownership-global-market-watch-2009-2015.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/arm222817-biobanking-end-users-global-market-watch-2009-2015.html">
  <dc:language>en</dc:language>
  <dc:date>2011-11-07</dc:date>
  <dc:creator>Axis Research Mind</dc:creator>
  <title>BIOBANKING: END-USERS - A GLOBAL MARKET WATCH, 2009-2015</title>
  <link>http://www.giiresearch.com/report/arm222817-biobanking-end-users-global-market-watch-2009-2015.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/infi222971-global-cardiac-markers-device-market-2010-2014.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2011-11-07</dc:date>
  <dc:creator>Infiniti Research Limited</dc:creator>
  <title>Global Cardiac Markers Device Market 2010-2014</title>
  <link>http://www.giiresearch.com/report/infi222971-global-cardiac-markers-device-market-2010-2014.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/hts225420-3d-cell-culture-trends-2011.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:date>2011-11-07</dc:date>
  <dc:creator>HTStec Ltd</dc:creator>
  <title>3D Cell Culture Trends 2011</title>
  <link>http://www.giiresearch.com/report/hts225420-3d-cell-culture-trends-2011.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc229431-canada-generics-biosimilars-overview.html">
  <dc:language>en</dc:language>
  <dc:subject>Generic Drugs</dc:subject>
  <dc:date>2011-11-03</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Canada: Generics and Biosimilars Overview</title>
  <link>http://www.giiresearch.com/report/dc229431-canada-generics-biosimilars-overview.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi219214-gpcrs-drug-discovery-efforts-de-orphanize-novel.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery</dc:subject>
  <dc:date>2011-11-01</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing</title>
  <link>http://www.giiresearch.com/report/gbi219214-gpcrs-drug-discovery-efforts-de-orphanize-novel.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/tk220781-cardiac-marker-diagnostic-testing-markets.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>In Vitro Diagnostics Equipment</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:date>2011-11-01</dc:date>
  <dc:creator>Trimark Publications</dc:creator>
  <title>Cardiac Marker Diagnostic Testing Markets</title>
  <link>http://www.giiresearch.com/report/tk220781-cardiac-marker-diagnostic-testing-markets.html</link>
  <description></description>
</item>
</rdf:RDF>
